A. Cascais

Prediction of Pharmacokinetic Profile of Valsartan in Humans Based on in vitro Uptake‐Transport Data

Thierry Lavé, Christoph Funk, Agnès Poirier, 2009, Chemistry & biodiversity.

Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data

Thierry Lavé, Christoph Funk, Agnès Poirier, 2009, Journal of Pharmacokinetics and Pharmacodynamics.

Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms

C. Funk, S. Dudal, F. Schuler, 2017, mAbs.

Minimizing DILI risk in drug discovery - A screening tool for drug candidates.

T. Singer, C. Funk, K. Youdim, 2015, Toxicology in vitro : an international journal published in association with BIBRA.

Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo

Alexander Hillebrecht, C. Funk, A. Poirier, 2014, Drug Metabolism and Disposition.

The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?

C. Funk, A. Poirier, M. Ullah, 2014, Drug Metabolism and Disposition.

Title : “ Calibration of in vitro MDR 1 substrate and inhibition assays as a basis to support the prediction of clinically relevant interactions in vivo

Alexander Hillebrecht, A. Poirier, A. Cascais, 2014 .

The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?

C. Funk, A. Poirier, M. Ullah, 2014, Drug Metabolism and Disposition.